Viewing Study NCT06405542



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06405542
Status: RECRUITING
Last Update Posted: 2024-05-08
First Post: 2024-05-02

Brief Title: Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy CIPN
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Study Overview

Official Title: EX-CIPN An Exercise-based Rehabilitation Intervention to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy CIPN
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EX-CIPN
Brief Summary: The goal of this clinical trial is to learn if the EX-CIPN exercise-based intervention is feasible acceptable and safe in participants with persistent chemotherapy-induced peripheral neuropathy CIPN It will also give insight on the effectiveness of the exercise intervention in treating CIPN symptoms The main questions it aims to answer are

Is EX-CIPN safe acceptable and feasible in cancer survivors experiencing persistent CIPN
Are the study design and methods feasible recruitment and retention rates feasibility of data collection and procedures

Researchers will provide all participants with the exercise-based intervention

Participants will

Complete assessments at baseline immediately post-intervention and 3-months post-intervention
Complete a 10-week remote individualized exercise program
Receive health coaching calls on weeks 2 3 4 6 and 8 of the intervention
Wear a FitBit throughout the study to track physical activity and promote behaviour change
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None